A study published by Addiction Journal highlights that the consumption of psilocybin, a hallucinogenic drug, doubled between 2018 and 2021 . Megan Patrick, co-author of the report, indicated that the findings and results of the study are difficult to explain:
Doubling the prevalence in just three years is a dramatic increase and raises potential public health concerns. It is really difficult to explain these trends.
Among US young adults, prevalence of past-year use non-LSD hallucinogen was twice as high in 2021 as in 2018
— Addiction Journal (@AddictionJrnl) June 16, 2023
The percentage of young adults (8%) who claimed to have tried some type of hallucinogenic drug in 2021 also reflects a steady increase: 3% (in 2011); 5% (2016) and 8% (2021), according to federal data.